Introduction
============

The culture of the Chilean scallop *Argopecten purpuratus* is the second most important industry in Chilean mariculture and is primarily concentrated in the north region of the country ([@B56]). However, recurrent episodes of larval mortalities mainly due to bacterial infections have been observed, causing high economical losses and consequently precluding the sustainability of this industry. These bacterial infections are commonly characterized by a sudden cessation of larval motility leading to massive mortalities of reared larvae. Previous studies demonstrated the pathogenic activity on scallop larvae of bacterial strains identified as *Halomonas* sp. ([@B43]), *Vibrio anguillarum*-related ([@B41]), *V.* *splendidus* ([@B44]) and the association of *Aeromonas hydrophila* and *V. alginolyticus* ([@B42]).

*Vibrio* species have been described worldwide as the main aetiological agents of bacterial pathologies affecting reared larvae of various shellfish species ([@B57]; [@B12]; [@B13]; [@B36], [@B35]; [@B44]; [@B9], [@B7]). Clinical symptoms commonly exhibited by reared shellfish larvae affected by vibriosis include the reduction of larval motility, erratic swimming, closing of valves, velum detachment and bacterial swarming inside and around the larvae ([@B2]; [@B44]). Most of these clinical signs were described in larval cultures of the clam species *Ruditapes decussatus* ([@B13]) and *R. philippinarum* ([@B8]), oyster species *Crassostrea virginica* ([@B14]) and *C. gigas* ([@B12]; [@B11]), and scallop species *Pecten maximus* ([@B31]; [@B54]), *Argopecten ventricosus* ([@B48]; [@B24]) and *Patinopecten yessoensis* ([@B23]). The pathogenicity of *Vibrio* strains causing vibriosis outbreaks is mediated by bacterial invasion ([@B44]; [@B8]) as well as the production of toxigenic extracellular products (ECPs) ([@B3]; [@B17]; [@B19]; [@B44]). Within the genus *Vibrio*, the Orientalis clade includes the species *V. crosai, V. orientalis,V. brasiliensis, V. sinaloensis, V. hepatarius* and the pathogenic species for bivalves *V. tubiashii, V. bivalvicida, and V. europaeus* ([@B8]). Recently, *V. europaeus* and *V. bivalvicida* have gained a relevant significance in Europe, since they were identified as the aetiological agents responsible of outbreaks of vibriosis that affected recurrently to Spanish and French hatcheries ([@B55]; [@B9]). Interestingly, pathogenicity of these species has been demonstrated in larvae of *R. decussatus, R*. *philippinarum, O. edulis, C. gigas, or Donax trunculus*, some of the most important bivalve species reared in the European hatcheries ([@B7]).

In general, 16S rRNA gene has a rather low interspecies resolution and is not useful for species differentiation but may provide a reliable identification at genus level. In genomic era, techniques as multilocus sequence analysis (MLSA) or whole genome sequencing (WGS) are essential to provide a better understanding of the taxonomic position of the pathogenic *Vibrio* isolates. [@B50] proposed that a MLSA based on the eight housekeeping genes *gap*A, *gyr*B, *fts*Z, *mre*B, *pyr*H, *rec*A, *rpo*A, and *top*A is a powerful method for delineating a species of the genus *Vibrio* and a monophyletic group or clade. In addition, WGS enabled the possibility of establishing systematics on the basis of complete genomes by means of genome to genome comparisons using for example the average nucleotide identity (ANI) algorithm to identify bacterial strains accurately ([@B40]).

Despite that efficient rearing techniques for scallop larvae production that have been developed, Chilean commercial hatcheries are currently suffering recurrent episodes of high mortalities of reared larvae, mainly associated with high levels of vibrios ([@B28]; [@B44]). The identification of bacterial strains causing epizootics in larval cultures and the understanding of their pathogenic activity are essential for the development of adequate and efficient protocols of larval management, as well as for the implementation of proper bacteriologic monitoring strategies to prevent and control scallop larvae mortality outbreaks occurring in commercial hatcheries. Considering that knowledge of the identity and pathogenic mechanisms of bacterial causing massive mortalities of scallop larvae reared in commercial hatcheries in Chile remains scarce, the aims of this study were to characterize and identify a highly pathogenic *Vibrio* strain recovered from a massive larval mortality event occurred in a commercial hatchery, to characterize its pathogenic properties and to describe the chronology of the pathology.

Materials and Methods {#s1}
=====================

Bacterial Isolation
-------------------

The pathogenic strain VPAP30 was recovered from a massive mortality event of reared-larvae of the scallop *A*. *purpuratus* occurring in a commercial hatchery located in Tongoy Bay in the north of Chile. Triplicate samples of settled dead and moribund larvae were aseptically collected from the bottom of the rearing tank during its water exchange using a sterile glass flask and were transported to the laboratory for immediate processing. Larval samples were centrifuged at 960 g for 2 min using an Eppendorf 5415D centrifuge (Hamburg, Germany) and the water excess was discarded. Settled larvae were ground by hand using a sterile glass digester containing 2 mL of sterile physiological saline (0.85% NaCl; PS) to obtain a homogenate according to the method of [@B31]. The homogenate was inoculated in triplicate onto Tryptic Soy Agar (Difco, NJ, United States) with 2% of NaCl (Oxoid, Hants, United Kingdom) (TSA2), and plates were incubated at 20°C for 48 h. The predominant colony, which grew almost as a pure culture on TSA2 plates, was isolated and preserved at -85°C in CryoBank (Mast Diagnostic, Merseyside, United Kingdom) vials prior use.

Biochemical and Physiological Characterization
----------------------------------------------

Phenotypic characterization to identify *Vibrio* species were performed with different tests following [@B32] such as cell morphology, Gram stain, oxidation/fermentation of glucose, and resistance to the vibriostatic agent O129 (2,4-diamino-6,7-diisopropylpteridine) (10 and 150 μg per disc) were determined according to the protocols described in [@B1]. In addition, other phenotypic properties of VPAP30 strain were determined. Production of luminescence was evaluated in absence of light by using Marine agar 2216 (Difco, NJ, United States), whereas β-haemolysis of red cells was determined by using Columbia Blood agar (Oxoid, Hants, United Kingdom). Production of Møller's lysine and ornithine decarboxylases and Thornley's arginine dihydrolase were detected according to [@B15]. Growth at 4, 20, 30, 35, and 40°C was tested on Tryptic Soy broth supplemented with 2% NaCl (TSB2) and growth at 0, 3, 6, 8, and 10% of NaCl was assayed using peptone broth (BD, Sparks, United States). Additional phenotypic characteristics of VPAP30 strain were determined by using the API 20E (bioMérieux, Marcy-l´Etoile, France) and the Biolog (Biolog Inc., Hayward, CA, United States) systems. For the API system the VPAP30 strain was inoculated according to the manufacturer's instructions with the modifications suggested by [@B25] and the API strip was incubated at 20°C for 48 h. For the Biolog system the strain was inoculated by using a solution containing 2.5% NaCl, 0.8% MgCl~2~, and 0.05% KCl, according to the instructions of the manufacturer and the microplate was aerobically incubated in the dark at 20°C for 72 h.

Enzymatic Analysis
------------------

The enzymatic activities of VPAP30 strain were determined by using the API ZYM system (bioMérieux, Marcy-l´Etoile, France) according to the manufacturer's guidelines. Briefly, VPAP30 strain was cultured overnight in TSB2, centrifuged at 4,200 g at 4°C and resuspended in a NaCl 0.85% solution (bioMérieux, Marcy-l´Etoile, France) to obtain a turbidity of 5 McFarland (1.5 × 10^9^ bacteria mL^-1^), and 65 μL of this suspension were added to each cupule. Test strips were incubated for 4 h at 20°C and following incubation, 1 drop of ZYM A (API; tris-hydroxymethyl-aminomethane, hydrochloric acid, sodium laurel sulfate, H~2~O) and ZYM B (API; fast blue BB, 2-methoxyethanol) were added to each cupule. Test strips were read after 5 min and the results were scored using the following classification: 0, negative reaction; 1--2 weak activity; 3--5 strong activity. The assay was performed twice to ensure reproducibility.

Phylogenetic Analysis
---------------------

DNA was extracted and purified from a pure culture using the Wizard Genomic DNA Purification Kit (Promega, Madison, WI, United States). PCR was performed as described in [@B47] with a reaction mixture (30 μL) containing 0.25 mM of each deoxynucleoside triphosphate, 0.05 U μL^-1^ Platinum Taq DNA polymerase (Invitrogen, San Diego, CA, United States), 1 × polymerase reaction buffer, 2 mM MgCl~2~, and 0.25 pmol μL^-1^ of each primer. To identify the bacterial strain, amplification of the 16S rRNA gene from positions 28 to 1,492 was performed using the primer pair 27F and 1492R as previously described ([@B30]). The housekeeping genes encoding for cell-division protein (*fts*Z), glyceraldehyde-3-phosphate dehydrogenase (*gap*A), gyrase beta subunit (*gyr*B), rod shape-determining protein (*mre*B), uridine monophosphate kinase (*pyr*H), recombinase A (*rec*A), RNA polymerase alpha subunit (*rpo*A), and topoisomerase I (*top*A) were used to perform a MLSA. Amplification of these genes was performed as previously described ([@B50]). PCR mixtures were identical to those previously used for the 16S rRNA gene, and the specific primers are listed in [Supplementary Table 1](#SM3){ref-type="supplementary-material"}. The thermal programme consisted of 5 min at 95°C, 25 cycles of 30 s at 95°C, 30 s at 55°C, and 30 s at 72°C, and a final 5 min extension at 72°C. All PCR products were verified, sequenced by Sanger and analyzed as described in [@B46] using the Ribosomal Database Project II ([@B4]) or were compared to those available in the National Center for Biotechnology Information (NCBI) Reference Sequence database by using a BLAST search to ascertain their closest relatives. Previously, the genome sequence data of the strain VPAP30 has been deposited at DDBJ/EMBL/GenBank under the accession number [LBLS00000000](LBLS00000000). Sequences obtained for each housekeeping gene were identical to those retrieved from the genome of the strain VPAP30 and they were included as a (Supplementary Material [1](#SM2){ref-type="supplementary-material"}). The sequences of the closest *Vibrio* species were obtained from GenBank and their accession numbers are listed in [Supplementary Table 1](#SM3){ref-type="supplementary-material"}. Phylogenetic analysis based on the individual and concatenated sequences were performed using the MEGA 6.0 software, after multiple alignments of data by ClustalW tool (BioEdit software). Distances and clustering with the Neighbour Joining (NJ), Maximum Likelihood (ML), and Maximum Parsimony (MP) algorithms were determined using bootstrap values based on 1,000 replications.

Availability in the GenBank/EMBL/DDBJ of the genomes corresponding to the species of the Orientalis clade (*V. tubiashii, V. bivalvicida, V. crosai, V. orientalis,V. brasiliensis, V. sinaloensis, V. hepatarius, and V. europaeus*) allowed us to establish a complete taxonomic study based on comparisons among genome assemblies with the strain VPAP30. ANI calculations were performed according to BLAST (ANIb) algorithm, using JSpeciesWS ([@B40]), whereas OrthoANI percentages were calculated as described [@B21]. In addition, DNA-DNA Hydridizations (DDH) were also calculated *in silico* by the Genome-to-Genome Distance Calculator (GGDC 2) using the BLAST+ method ([@B26]). Results were based on recommended formula 2 (identities/HSP length), which is independent of genome length and is thus robust against the use of incomplete draft genomes.

Time Course of the Infection
----------------------------

The pathogenic activity time course for the VPAP30 strain was studied using an *in vitro* challenge assay. Healthy 10 days old scallop larvae were added to each well of a 12-well tissue culture plate (Orange Scientific, Braine-l'Alleud, Belgium) containing 4 mL of 0.22 μm-filter sterilized seawater to obtain a final concentration of 20 larvae mL^-1^ and were challenged with a final approximate concentration of 8.0 ± 1.0 × 10^5^ CFU mL^-1^ of the VPAP30 strain. The pathogen *V. pectenicida* A365 ([@B20]) was included as a positive control using identical conditions. Plates were incubated at 18°C for 48 h in the dark. The proportion of live and dead larvae was determined at 6, 12, 18, 24, 30, 36, 42, and 48 h, and the symptoms of the pathology were recorded using the inverted microscope Olympus CKX41 (Tokyo, Japan). Larvae were considered dead when no movement was observed within the valves. Larvae not inoculated with bacteria were use as negative control. The pathogenic activity of the VPAP30 strain on scallop larvae was demonstrated by re-isolating the VPAP30 strain from moribund experimentally infected larvae, thereby fulfilling Koch's postulates.

Estimation of LD~50~ (50% Lethal Dose)
--------------------------------------

The virulence of the VPAP30 strain was estimated by determining its 50% lethal dose (LD~50~) values after 24 and 48 h of exposure, according to [@B37]. The LD~50~ was defined as the dose of the VPAP30 strain required to kill 50% of infected scallop larvae. The VPAP30 strain was tested for its pathogenicity in triplicate using 12-well tissue culture plates (Orange Scientific, Braine-l'Alleud, Belgium). Scallop larvae were added to each well of the tissue culture plate containing 4 mL of 0.22 μm filter sterilized seawater at a concentration of 20 larvae mL^-1^, and the VPAP30 strain was added to the wells to obtain final concentrations of 1.4 ± 0.4 × 10^2^, 1.4 ± 0.4 × 10^3^, 1.4 ± 0.4 × 10^4^, and 1.4 ± 0.4 × 10^5^ CFU ml^-1^, using six wells per plate for each concentration. The inverted microscope Olympus CKX41 (Tokyo, Japan) was used to determine the numbers of live and dead larvae at 24 and 48 h post-inoculation. A group of larvae were also inoculated with filtered seawater as negative control.

Pathogenic Activity of Extracellular Products (ECPs)
----------------------------------------------------

The ECPs produced by the VPAP30 and *V. pectenicida* A365 strains were obtained using the cellophane overlay plate method ([@B22]). Briefly, a volume of 0.2 mL of a 36 h culture of each bacterial strain grown in TSB2 was spread onto sterile cellophane films placed onto TSA2 plates and incubated at 20°C for 36 h. Cellophane overlays were transferred to empty Petri dishes and bacterial cells were washed off from the cellophane sheet using phosphate buffered saline (PBS, pH 7.4) and removed by centrifugation at 13,250 g for 20 min at 4°C. Supernatants were sterilized by filtration through a 0.22 μm filter (Sartorious Stedim Biotech, Germany) and stored at -85°C until use. Total protein concentrations of supernatants were measured using the Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, United States) and were read at 562 nm using a Microplate Reader Asys UVM 340 (biochrom, Cambridge, United Kingdom). Ten days old scallop larvae were added at a concentration of 20 larvae mL^-1^ to each well of a 12-well microplate (Orange Scientific, Braine-l'Alleud, Belgium) containing 3.8 mL of microfiltered seawater and then inoculated in triplicate with 0.2 mL of the cell-free supernatant to obtain a final concentration of 4 μg protein mL^-1^. Larval cultures inoculated with 0.2 mL of PBS were used as controls. Microplates were incubated at 18°C for 48 h in the dark and the proportion of dead larvae was determined at 12, 24, 36, and 48 h using the inverted microscope Olympus model CKX41 (Tokyo, Japan). In addition, supernatant samples of VPAP30 and *V. pectenicida* A365 strains were heated at 125°C for 15 min, and the pathogenic activity of treated supernatants was assayed in triplicate, as previously described.

Invasive Pathogenic Activity
----------------------------

The methodology of [@B51] to label bacteria with 5-(\[4,6-dichlorotriazin-2-yl\]amino) fluorescein hydrochloride (5-DTAF, Sigma--Aldrich, D-0531, St. Louis, MO, United States) was modified to obtain the best labeling conditions for the *Vibrio* strain. The pathogenic strain was cultured in TSB2 (Difco) at 20°C for 24 h with shaking at 100 rpm using an orbital shaker (WiseShake SHO- 2D, Daihan Scientific, Gangwon-do, Korea). The broth was centrifuged at 5,725 g for 8 min, then the bacterial pellet was resuspended in 10 mL of sterile seawater and the optical density was adjusted to 0.8--1.3 at 610 nm in a spectrophotometer (PG Instruments T70, Leicestershire, United Kingdom) under aseptic conditions. The 5-DTAF was dissolved in 0.22 μm-filtered PBS (pH 7.4) to obtain a final concentration of 0.5 mg mL^-1^. A 0.5 mL aliquot of the 5-DTAF solution was added to 9.5 mL of the bacterial suspension, and the mixture was incubated at 20°C for 1 h in total darkness with shaking at 90 rpm. After incubation, the bacterial culture was pelleted by centrifugation (5,725 g for 6 min) and resuspended in 0.22 μm-filtered seawater and the procedure was repeated until an unstained suspension was observed. Healthy 10 days old scallop larvae of *A*. *purpuratus* maintained in 12-well microplates (Orange Scientific, Braine-l'Alleud, Belgium) at a density of 20 larvae mL^-1^ were inoculated in triplicate with the stained VPAP30 strain to obtain a final concentration of 1 × 10^5^ CFU mL^-1^ and were observed at 0.5, 1, 4, 6, 12, 18, and 24 h using the Nikon fluorescence microscope Eclipse 50i. Bacterial concentrations were confirmed by a standard dilution plating technique as previously described ([@B44]). Larval cultures inoculated with unstained pathogenic strain as well as larval cultures not inoculated with the assayed strain were included as controls. The bioassay was performed twice to confirm reproducibility.

Production of Virulence Factors
-------------------------------

Production of the virulence factors caseinase, gelatinase, lipase, β-haemolysin and phospholipase were determined as described by [@B29]. For the lipase and phospholipase assays, marine agar 2216 (Difco, NJ, United States) (MA) plates were supplemented with 1% Tween 80 (Sigma-Aldrich, St. Louis, MO, United States) or 1% egg yolk emulsion (Oxoid, Hants, United Kingdom), respectively. The development of opalescent zones around the colonies after 2 days of incubation at 20°C was considered a positive result. The caseinase assay plate was prepared by mixing double strength MA with a 4% skim milk powder suspension (Oxoid, Hants, United Kingdom), and sterilized separately at 121°C for 5 min. Clearing zones around the bacterial colonies grown after 2 days of incubation at 25°C were considered a positive result. Gelatinase assay plates were prepared by mixing 0.5% gelatine (Sigma-Aldrich, St. Louis, MO, United States) into MA. After incubation for 4 days, saturated ammonium sulfate (80%) in distilled water was poured over the plates and after 2 min, clearing zones around the colonies were considered a positive result. β-haemolytic activity was determined using Columbia Blood agar (Oxoid, Hants, United Kingdom), and clearing of the agar around the colony after 2 days of incubation at 25°C was considered a positive result. All assays were performed in triplicate.

Statistical Analysis
--------------------

Larval survival percentages were transformed to arcsin \[square root (survival rate ration)\] and were compared using one-way ANOVA. When overall differences were significant, *a posteriori* Tukey's multiple range test was used to determine significant differences (*P* \< 0.05). Furthermore, the log-rank test was used to compare the survival rates of larval groups not infected, infected with VPAP30 and infected with *V. pectenicida* A365 using the Kaplan-Meier procedure. All statistical analyses were performed using SigmaStat 3.1 (Systat Software Inc.).

Biological Safety Procedures
----------------------------

All material contaminated with microorganisms, as well as all used bacterial cultures were discarded after sterilization by autoclaving.

Results
=======

Phenotypic Characterization
---------------------------

The pathogenic strain showed phenotypic properties characteristic of the genus *Vibrio* ([@B52]). The VPAP30 strain was a Gram-negative, motile short rod, positive for oxidase and catalase tests, susceptible to O/129 and unable to grow in the absence of NaCl ([Table 1](#T1){ref-type="table"}). The VPAP30 strain was able to produce arginine dihydrolase, indole and gelatinase, acid and gas from glucose, and degradation of amygdalin, whereas it was unable to produce the enzymes tryptophan deaminase, lysine decarboxylase and ornithine decarboxylase, as well as acetoin, H~2~S from glucose, and acid from sugars such as arabinose, inositol, mannitol, mannose, melibiose, rhamnose, and sorbitol. Additionally, the VPAP30 strain was positive for citrate production, growing as yellow colonies on TCBS medium and acid production from sucrose, whereas it was unable to grow at 4, 35, and 40°C. The API ZYM profile of the VPAP30 strain is presented in [Table 2](#T2){ref-type="table"} showing the capacity to produce the enzymes alkaline phosphatase, leucine arylamidase, trypsin and naphthol-AS-BI-phosphohydrolase, as well as weak production of valine arylamidase. Several phenotypic tests differentiated the VPAP30 strain from the closest related *Vibrio* species belonging to the Orientalis clade, such as being negative for lysine decarboxylase activity and absence of growth at 8% NaCl.

###### 

Phenotypic characteristics of *Vibrio bivalvicida* VPAP30.

  Characteristic            Characteristic                                 
  ------------------------- ---------------- ----------------------------- ----
  Morphology                Rod              Citrate                       \+
  Motility                  \+               Gelatinase production         \+
  Gram stain                --               Gas from glucose              \+
  Growth on TCBS            \+               Indole production             \+
  O/F Glucose               F                Reduction of NO~3~ to NO~2~   \+
  Oxidase                   \+               β-galactosidase (ONPG)        --
  Catalase                  \+               Swarming on solid media       --
  Arginine dihydrolase      \+               Urease                        --
  Luminiscence              --               Voges -- Proskauer            --
  Lysine decarboxylase      --               Acid from:                    
  Ornithine decarboxylase   --               Arabinose                     --
  Growth at 0% NaCl         --               Inositol                      --
  Growth at 3% NaCl         \+               Manitol                       --
  Growth at 6% NaCl         \+               D -- mannose                  --
  Growth at 8% NaCl         --               Melibiose                     --
  Growth at 10% NaCl        --               Rhamnose                      --
  Growth at 4°C             --               Sorbitol                      --
  Growth at 20°C            \+               Sucrose                       \+
  Growth at 30°C            \+               Susceptibility to:            
  Growth at 35°C            --               O/129 (10 μg)                 \+
  Growth at 40°C            --               O/129 (150 μg)                \+

F, Fermentative; O/F, oxidation-fermentation; ONPG, o-nitrophenyl-β-galactosidase.

###### 

Enzymatic properties of *V*. *bivalvicida* VPAP30 strain by using the API ZYM system (Biomerieux).

  Enzyme                            Results
  --------------------------------- ----------
  Control                           Negative
  Alkaline phosphatase              Strong
  Esterase (C~4~)                   Negative
  Esterase lipase (C~8~)            Negative
  Lipase (C~14~)                    Negative
  Leucine arylamidase               Strong
  Valine arylamidase                Weak
  Cystine arylamidase               Negative
  Trypsin                           Strong
  α-Chymotrypsin                    Negative
  Acid Phosphatase                  Negative
  Naphthol-AS-BI-Phosphohydrolase   Strong
  α-Galactosidase                   Negative
  β-Galactosidase                   Negative
  β-Glucoronidase                   Negative
  α-Glucosidase                     Negative
  β-Glucosidase                     Negative
  *N*-Acetyl-β-glucosaminidase      Negative
  α-Mannosidase                     Negative
  α-Fucosidase                      Negative

Further phenotypical characterization by using the Biolog system, demonstrated that VPAP30 strain was able to use as a sole carbon source, dextrin, glycogen, tween 40, tween 80, N-acetil-D-glucosamine, D-cellobiose, D-fructose, D-galactose, α-D-glucose, maltose, D-mannose, D-melibiose, sucrose, acetic acid, β-hydroxy butyric acid, α-keto butyric acid, D,L-lactic acid, succinic acid, bromo succinic acid, L-alanine, L-alanyl glycine, L-asparagine, L-aspartic acid, L-glutamic acid, glycyl-L-aspartic acid, glycyl-L-glutamic acid, L-histidine, L-ornithine, L-proline, D-serine, L-threonine, inosine, uridine, thymidine, and glycerol ([Supplementary Table 2](#SM3){ref-type="supplementary-material"}).

Taxonomic Affiliation of the Strain VPAP30
------------------------------------------

Molecular identification of the VPAP30 strain was determined by16S rDNA sequence analysis (1,350 bp). The phylogenetic tree constructed from evolutionary distances of 15 representative strains using the NJ algorithm method is shown in [Supplementary Figure 1](#SM1){ref-type="supplementary-material"}, showing that the amplified sequence of VPAP30 strain was identical to *V*. *bivalvicida* (100% of similarity). Furthermore, the 16S rRNA sequence of VPAP30 strain was aligned with reference using the public database of EzBio Cloud^[1](#fn01){ref-type="fn"}^ website and confirmed *V. bivalvicida* 605^T^ (Accession number [LLEI01000012](LLEI01000012)) as the closest relative for the strain VPAP30.

In addition, we have performed an MLSA using the concatenation of (5,480 bp) eight housekeeping genes for encoding various functions (*ftsZ, gapA, gyrB, mreB, pyrH, recA, rpoA*, and *topA*) to improve the taxonomic resolution ([@B50]). For this, we have included in the phylogenetic analysis all type strains of the species belonging to Orientalis clade as well as other representative strains such as *V. coralliilyticus* RE98, strain isolated from diseased oyster larvae ([@B38]), and previously miss-classified as *V. tubiashii* ([@B11]). The resulting phylogenetic tree is shown in [Figure 1](#F1){ref-type="fig"}, in which the Orientalis clade, updated recently by [@B8] is highlighted. Within Orientalis clade, the VPAP30 strain and *V. bivalvicida* formed clearly a cluster separated from the other species. Percentages released from comparisons of the concatenated gene sequences revealed that the VPAP30 shared a 99.5% similarity with *V. bivalvicida*, whereas *V. europaeus* was the second nearest species with 92.7% identity.

![Phylogenetic tree based on concatenated sequences of the housekeeping genes *ftsZ, gapA, gyrB, mreB, pyrH, recA, rpoA*, and *topA* obtained by the neighbor-joining method. Horizontal branch lengths are proportional to evolutionary divergences. Bootstrap from 1,000 replicates appears next to the corresponding branch. *Photobacterium damselae* was used as an outgroup.](fmicb-10-00855-g001){#F1}

Genome to genome comparisons between the strain VPAP30 and the closest relatives confirmed definitely its taxonomic position within the Orientalis clade. ANIb and OrthoANI percentages between the VPAP30 strain and the closest relatives were 97.9 and 98.2%, respectively, to *V. bivalvicida* 605^T^ and were 86.0 and 86.5%, respectively, to *V. tubiashii* ATCC 19109^T^ ([Table 3](#T3){ref-type="table"}). Results supported the affiliation of the VPAP30 strain as *V. bivalvicida* since ANI values were clearly above than the proposed cut-off values for species boundary (95∼96%) ([@B39]).

###### 

Genomic comparisons between the species belonging to the Orientalis clade, including ANI calculations (ANIb and OrthoANI) and *in silico* DNA--DNA hybridizations (GGDC).

                                       1\.         2\.         3\.     4\.     5\.     6\.     7\.     8\.
  ------------------------------------ ----------- ----------- ------- ------- ------- ------- ------- -------
  **ANIb**                                                                                             
  1\. *V. bivalvicida* 605^T^          --          **97.94**   85.21   85.03   77.30   77.06   75.54   74.91
  2\. *V. bivalvicida* VPAP30          **97.96**   --          85.99   85.87   77.27   76.99   61.35   74.91
  3\. *V. tubiashii* ATCC 19109^T^     85.24       85.95       --      93.86   77.57   77.49   75.93   75.36
  4\. *V. europaeus* PP-638^T^         84.96       85.80       93.76   --      77.27   77.21   75.76   75.14
  5\. *V. orientalis* CIP 102891^T^    77.48       77.40       77.61   77.36   --      77.29   75.69   75.19
  6\. *V. brasiliensis* LMG 20546^T^   77.10       77.05       77.41   77.33   77.26   --      75.40   75.33
  7\. *V. sinaloensis* DSM 21326       75.60       75.61       75.90   75.75   75.56   75.37   --      75.44
  8\. *V. hepatarius* DSM 19134^T^     74.95       74.93       75.37   75.07   75.04   75.25   75.39   --
  **ORTHOANI**                                                                                         
  1\. *V. bivalvicida* 605^T^          --          **98.24**   85.73   85.34   77.95   77.52   76.23   75.71
  2\. *V. bivalvicida* VPAP30          **98.24**   --          86.50   86.37   77.91   77.43   76.20   75.62
  3\. *V. tubiashii* ATCC 19109^T^     85.73       86.50       --      94.17   78.05   78.01   76.64   75.97
  4\. *V. europaeus* PP-638^T^         85.34       86.37       94.17   --      77.80   77.81   76.46   75.89
  5\. *V. orientalis* CIP 102891^T^    77.95       77.91       78.05   77.80   --      77.93   76.13   75.81
  6\. *V. brasiliensis* LMG 20546^T^   77.52       77.43       78.01   77.81   77.93   --      75.99   75.94
  7\. *V. sinaloensis* DSM 21326       76.23       76.20       76.64   76.46   76.13   75.99   --      76.05
  8\. *V. hepatarius* DSM 19134^T^     75.71       75.62       75.97   75.89   75.81   75.94   76.05   --
  **GGDC**                                                                                             
  1\. *V. bivalvicida* 605^T^          --          **84.20**   29.90   29.60   21.60   21.20   21.00   19.90
  2\. *V. bivalvicida* VPAP30          **84.20**   --          31.30   31.00   21.50   21.20   20.90   19.90
  3\. *V. tubiashii* ATCC 19109^T^     29.90       31.30       --      56.10   22.00   21.50   21.30   20.70
  4\. *V. europaeus* PP-638^T^         29.60       31.00       56.10   --      21.70   21.40   21.10   20.30
  5\. *V. orientalis* CIP 102891^T^    21.60       21.50       22.00   21.70   --      21.40   20.90   20.30
  6\. *V. brasiliensis* LMG 20546^T^   21.20       21.20       21.50   21.40   21.40   --      20.40   20.30
  7\. *V. sinaloensis* DSM 21326       21.00       20.90       21.30   21.10   20.90   20.40   --      20.10
  8\. *V. hepatarius* DSM 19134^T^     19.90       19.90       20.70   20.30   20.30   20.30   20.10   --

1\. V. bivalvicida 605

T

(LLEI00000000); 2. V. bivalvicida VPAP30 (LBLS00000000); 3. V. tubiashii ATCC 19109

T

(CP009354, CP009355, CP009356, CP009357, CP009358, and CP009359); 4. V. europaeus PP-638

T

(LUAX00000000); 5. V. orientalis CIP 102891

T

(ACZV00000000); 6. V. brasiliensis LMG 20546

T

(AEVS00000000); 7. V. sinaloensis DSM 21326 (AEVT00000000); 8. V. hepatarius DSM 19134

T

(LHPI00000000). Comparison values between V. bivalvicida VPAP30 and V. bivalvicida 605

T

strains are in bold.

As expected, genomic comparison between the draft genome of the VPAP30 strain and *V. bivalvicida* 605^T^ yielded 84.2% DDH similarity, clearly higher than the limit (70%) for delineation of prokaryotic species ([@B26]), contrasting with the phylogenetic distance of the VPAP30 strain with *V. tubiashii* ATCC 19109^T^ (31.5% DDH). Overall, the results obtained from the genomic analyses, including MLSA, ANI and DDH, supported the taxonomic affiliation of the strain VPAP30 as *V. bivalvicida*. Interestingly, the phenotypic profile of the VPAP30 strain is consistent with the characteristics described for *V. bivalvicida* ([@B9]), except for the use of D-Glucosamine as carbon source and fermentation of Melibiose ([Table 4](#T4){ref-type="table"}).

###### 

Comparative phenotypic characteristics of *V*. *bivalvicida* (VPAP30) and *Vibrio* species belonging to the Orientalis Clade.

  Test                           1    2    3    4    5    6    7    8
  ------------------------------ ---- ---- ---- ---- ---- ---- ---- ----
  Arginine dihydrolase           \+   \+   \+   \+   D    \+   \+   \+
  Lysine decarboxylase           --   --   --   --   \+   --   --   --
  Growth at 0% NaCl              --   --   --   --   --   --   \+   --
  Growth at 8% NaCl              --   --   v    --   \+   \+   \+   --
  Growth at 4°C                  --   --   --   --   \+   --   \+   --
  Growth at 40°C                 --   --   --   --   --   v    --   \+
  Citrate                        \+   \+   \+   \+   \+   --   \+   \+
  Voges-Prokauer                 --   NA   --   NA   --   --   \+   \+
  Indole production              \+   \+   \+        \+   --   \+   \+
  ONPG                           --   --   \+   \+   v    \+   --   \+
  Use of α-Ketoglutarate as cs   --   NA   --        --   --   NA   --
  Use of D-Glucosamine as cs     --   \+   v    \+   v    NA   \+   \+
  Use of Lactose as cs           --   --   --   --   --   --   --   --
  Fermentation of:                                                  
  Melibiose                      --   \+   v    NA   NA   NA   --   --
  Arabinose                      --   --   NA   --   NA   NA   --   \+

1, V. bivalvicida (this study); 2, V. bivalvicida 605 (

Dubert et al., 2016a

); 3, V. tubiashii (

Noguerola and Blanch, 2008

); 4, V. europaeus (

Dubert et al., 2016c

); 5, V. orientalis (CAIM332

T

); 6, V. sinaloensis (CAIM 797

T

); 7, V. hepatarius (

Thompson et al., 2003

); 8, V. brasiliensis (

Thompson et al., 2003

).

+, positive; -, negative; NA, data not available; d, discrepancies exist; v, variable results; cs, carbon source.

Bacterial Pathogenic Activity
-----------------------------

Pathogenic activity of the VPAP30 strain was demonstrated by infecting healthy scallop larvae with VPAP30 and *V*. *pectenicida* A365 strains, demonstrating that both pathogenic strains produced high levels of larval mortality ([Figure 2](#F2){ref-type="fig"}). However, the VPAP30 strain produced significantly (*P* \> 0.001) higher levels of larval mortality than those produced by the *V*. *pectenicida* strain during all the challenge assays. After 24 h of exposure, larval survival of larvae challenged with the VPAP30 strain was 34.3 ± 4.9%, significantly (*P* \< 0.001) lower than that observed in larvae challenged with *V*. *pectenicida* A365 (77.8 ± 4.6%) and not challenged larvae (100%). Larval survival at 36 h post-inoculation with the VPAP30 strain was 0%, significantly (*P* \< 0.001) lower than that observed in larvae challenged with *V*. *pectenicida* (61.0 ± 3.6%). Not challenged larvae exhibiting a survival of 97.4 ± 1.2% after a period of 48 h. The LD~50~ for the VPAP30 strain at 24 and 48 h was 1.3 × 10^4^ and 1.2 × 10^3^ CFU mL^-1^, respectively.

![Survival of 10 days old scallop larvae not challenged (control) and challenged with 1 × 10^5^ CFU mL^-1^ of *Vibrio bivalvicida* VPAP30 and *Vibrio pectenicida* A365. Values are a mean (±SD) of three replicates. Asterisks indicate significant differences.](fmicb-10-00855-g002){#F2}

The VPAP30 strain produced on challenged scallop larvae, the classical signs of vibriosis affecting mollusc larvae. These signs were identical to those observed in the larval culture suffering a vibriosis outbreak that developed in the commercial hatchery when the VPAP30 strain was recovered. The main clinical symptoms exhibited by larvae infected with the VPAP30 strain were disruption of the velum, ciliary cells detached from the velum and necrosis of the digestive gland tissue ([Figure 3](#F3){ref-type="fig"}). Erratic swimming was the first clinical sign and appeared at 6 h post-infection. At 12 h post-infection, the majority of challenged larvae showed destruction of the velum and necrosis of the digestive gland, whereas bacterial swarms around the larvae were observed after 24 h.

![Main clinical signs exhibited by *Argopecten purpuratus* larvae infected with *Vibrio bivalvicida* VPAP30 after 24 h of exposure. **(A)** Bacterial swarms of bacteria on the margins of the larvae, **(B)** velum disruption, **(C)** detachment of ciliary cells of the velum (black arrows), and **(D)** necrosis of digestive tissue of scallop larvae stained with trypan blue. Scale bars: 30 μm.](fmicb-10-00855-g003){#F3}

Invasive Pathogenic Activity
----------------------------

The VPAP30 strain was efficiently stained with 5-DTAF and fluorescence was maintained for at least 36 h ([Figure 4A](#F4){ref-type="fig"}), permitting the use of stained bacterial cells to visualize the invasive ability of the pathogenic strain along the time. The stained VPAP30 strain was detected at a low concentration in the digestive gland of challenged scallop larvae after 30 min of infection ([Figure 4B](#F4){ref-type="fig"}), increasing to high levels after 1 h of infection ([Figure 4C](#F4){ref-type="fig"}). Later, at 24 h post-infection, cells of the VPAP30 strain were detected at high concentrations in all larval tissues as well as around the larval shells ([Figure 4D](#F4){ref-type="fig"}).

![Invasive activity of *V*. *bivalvicida* VPAP30 strain on larvae of scallop *Argopecten purpuratus* determined by epifluorescence microscopy. **(A)** Bacterial cells of *V*. *bivalvicida* VPAP30 stained with 5-DTAF **(A)**; Stained *V*. *bivalvicida* in the digestive gland at 30 min post-infection **(B)**; Bacterial cells of *V*. *bivalvicida* in the digestive gland at 1 h post-infection **(C)**; Bacterial cells invading completely the larval body cavity and surrounding shell at 24 h post-infection. (Dg) Digestive gland; (Ve) Velum; (Mo) Mouth. Scale bars: 10 μm **(A)**; 50 μm **(B--D)**.](fmicb-10-00855-g004){#F4}

Pathogenic Activity of ECPs
---------------------------

When scallop larvae were exposed to ECPs produced by VPAP30 and *V*. *pectenicida* A365 strains, they exhibited identical symptoms to those observed during bacterial challenges. At 12 h post-inoculation with the ECPs of VPAP30 and *V*. *pectenicida* strains, percentages of larval survival were 88.6 ± 2.7% and 90.3 ± 2.5%, respectively. Survival rates of larvae infected with VPAP30 and *V*. *pectenicida* strains remained at levels not significantly different (*P* \< 0.05) until 36 h post-inoculation (69.0 ± 0.7% and 67.0 ± 5.0%, respectively). However, at 48 h post-inoculation, ECPs of *V*. *pectenicida* produced a larval survival of 41.9 ± 5.4%, significantly (*P* \< 0.05) lower than that produced by the ECPs of the VPAP30 strain (59.5 ± 1.7%), whereas larval survival of the control group was 97.4 ± 1.2% ([Figure 5](#F5){ref-type="fig"}). When heat-treated ECPs of the VPAP30 strain were assayed, their pathogenic activity remained present, and treated larvae exhibited survival rates of 74.3 ± 2.0% and 61.6 ± 1.8% after 36 and 48 h of exposure, respectively. Otherwise, the enzymatic activity of the untreated and heat-treated ECPs showed that only naphthol-AS-BI-phosphohydrolase activity remains in the heat-treated ECPs of *V*. *bivalvicida* and *V*. *pectenicida* strains ([Table 5](#T5){ref-type="table"}).

![Survival of 10 days old scallop larvae not challenged (control) and challenged with extracellular products of *V*. *bivalvicida* VPAP30 and *V*. *pectenicida* A365. Values are a mean (±SD) of three replicates. Asterisks indicate significant differences.](fmicb-10-00855-g005){#F5}

###### 

Comparative enzymatic activities displayed by whole cells and Extracellular Products (ECPs) of *Vibrio bivalvicida* VPAP30 and *V*. *pectenicida* A365.

  Enzymatic activity                *Vibrio bivalvicida*   *Vibrio pectenicida*                  
  --------------------------------- ---------------------- ---------------------- ---- ---- ---- ----
  Alkaline phosphatase              \+                     --                     \+   \+   --   \+
  Leucine arylamidase               \+                     --                     \+   --   --   --
  Valine arylamidase                \+                     --                     \+   --   --   --
  Trypsin                           \+                     --                     \+   --   --   --
  Acid phosphatase                  --                     --                     --   \+   --   \+
  Naphthol-AS-BI-phosphohydrolase   \+                     \+                     \+   \+   \+   \+
  *N*-Acetyl-β-glucosaminidase      --                     --                     --   \+   --   \+

Discussion
==========

One of the most important problems to define the current *Vibrio* species pathogenic to bivalve larvae and spat is related with their misleading taxonomic affiliation. In genomic era, techniques as MLSA or WGS are essential to provide a better understanding of the taxonomic position of the pathogenic *Vibrio* isolates and then to define them accurately ([@B49], [@B50]). Results obtained from the taxonomic analyses, including MLSA, DDH, and ANI, as well as phenotypic tests supported accurately the taxonomic affiliation of the strain VPAP30 as *V. bivalvicida.* [@B8] described this species for the first time through the characterization of three strains isolated in a shellfish hatchery located in Galicia (North West of Spain) from healthy broodstock, and moribund reared larvae and larval tank water of a culture of the carpet shell clam, *R. decussatus*. Virulence of this species was demonstrated in larvae of various clam species (*R. decussatus, R. philippinarum, Donax trunculus*) and flat oyster (*Ostrea edulis)*, some of the most important bivalve species reared in the European hatcheries ([@B7]). Present study constitutes the first report of the isolation of *V. bivalvicida* out of Europe and extend the host range of this species to the Chilean scallop larvae (*A. purpuratus*), supporting the potential threat for the shellfish hatcheries in the Atlantic and Pacific coasts.

The high concentration of *V. bivalvicida* VPAP30 strain in the dead and moribund scallop larvae samples, recovered almost as a pure culture in a non-selective bacteriological medium, the high pathogenic activity on experimentally infected scallop larvae, resemblance of the chronology of the pathology as well as the capacity to produce the same pathological symptoms exhibited by the sampled scallop larvae, strongly support the hypothesis that the mortality event that occurred in the commercial scallop hatchery in Chile was primarily caused by this strain. Notably, the high density and predominance of the colony morphotype of the VPAP30 strain was not observed in agar plates seeded with rearing tank water and swimming larvae samples. Furthermore, in a similar study, the primary pathogenic role of three *V. splendidus* strains in hatchery-reared scallop larvae was previously demonstrated in a similar manner, fulfilling the Koch's postulates ([@B44]). These recent studies suggest that despite good sanitary conditions and preventive measures, such as efficient influent water treatment strategies, a high diversity of *Vibrio* species exhibiting important virulence factors frequently enter to larval rearing tanks, thus exposing Chilean scallop hatcheries to recurrent vibriosis outbreaks.

This study demonstrated the high virulence of strain VPAP30, identified as *V*. *bivalvicida*, which produced the mortality of the entire challenged population of healthy scallop larvae after a period of 36 h. The clinical signs caused by the VPAP30 strain resembled those previously described for larval vibriosis occurring in various bivalve species, such as clams, oysters and scallops ([@B13]; [@B54]; [@B11]; [@B36]; [@B44]; [@B8]). Furthermore, the LD~50~ value of the VPAP30 strain was similar to the values reported for three highly pathogenic *Vibrio* strains pathogenic to Pacific oyster larvae, with values of approximately 10^4^ CFU mL^-1^ and 10^3^ CFU mL^-1^ after 24 and 48 h, respectively ([@B12]), but it must be noted that some of these strains have been re-classified as *V. coralliilyticus* ([@B58]; [@B38]). The *V. bivalvicida* VPAP30 strain showed to be more virulent that *V. bivalvicida* 605 and *V. bivalvicida* 194 strains ([@B9]), since the larvae of the *O*. *edulis, R*. *philipinarum*, and *D*. *trunculus* showed the typical signs of vibriosis after 48 h when were inoculated at a final concentration of 10^6^ CFU mL^-1^.

The observed pathogenic activity of the VPAP30 strain is remarkably higher than that produced by other *Vibrio* species pathogenic to mollusc larvae. For example, [@B59] estimated a LD~50~ of ∼6 × 10^6^ CFU mL^-1^ for a *Vibrio parahaemolyticus*-related strain pathogenic to larvae of *Meretrix meretrix*, 100-fold higher than the LD~50~ value of the VPAP30 strain. In another study, *V. parahaemolyticus*-related strain caused 100% mortality only after 6 days of challenge ([@B48]), contrasting with the high virulence exhibited by the VPAP30 strain, which killed all challenged larvae after 36 h of exposure.

The *V. bivalvicida* VPAP30 strain was able to invade the scallop larvae entering through the mouth to the digestive system and colonizing the body cavity and surface of the shell. These results of invasive activity are consistent with the observed by [@B8] for the pathogenic species tagged with GFP *V*. *neptunius* PP-145.98, *V*. *europaeus* PP-638^T^, formerly *V. tubiashii* subsp. *europaeus* ([@B10]), and *V*. *bivalvicida* 605^T^ on Manila clam larvae. These authors defined three stages in the infective process caused by these pathogenic species as follows: (1) during the first 2 h of infection, *Vibrio* strains were filtered by larval vellum and entered the digestive system through the esophagus and stomach colonizing the digestive gland and intestine; (2) then, *Vibrio* strains spread and proliferated to the surrounding organs in the body cavity (6--8 h post infection), and (3) after 14 h of challenge, the body cavity was completely colonized by *Vibrio* strains. Interestingly, DTAF-stained cells of the VPAP30 strain maintained their virulence on scallop larvae producing high mortality as well as the clinical signs typical of vibriosis. Therefore, the use of bacterial cell staining with 5-DTAF to study the chronology of invasive processes caused by *Vibrio* species is a time-saving protocol, highly recommended to follow the vibriosis on mollusc larvae.

Additionally, the pathogenic activity of *V. bivalvicida* VPAP30 strain mediated by the production of ECPs was evaluated. Our results demonstrated that cell-free ECPs of the VPAP30 strain are involved in the pathogenic action on scallop larvae, causing a mortality of 40% of challenged larvae after 48 h of exposure. The results of this study demonstrate that the extracellular toxigenic activity exhibited by this strain is mainly mediated by the production of heat stable compounds, causing larval necrosis and the detachment of ciliary cells, consistent with previous reports, which demonstrated that *Vibrio* strains can produce heat stable ciliostatic toxins and proteinases that degrade larval tissue ([@B6]; [@B34]). Furthermore, [@B55] demonstrated the toxicity of ECPs produced by the French *V. europaeus* 07/118 T2, formerly *V. tubiashii* ([@B10]), on the oyster *C. gigas*, producing a mortality of 41% after 2 days of challenge. In addition, the enzymatic activities of ECPs released by strains belonging to the *V*. *europaeus, V. neptunius*, and *V*. *bivalvicida* species were determined by [@B8] using API ZYM, primarily describing a protease activity. In contrast to the results obtained by [@B8], the pathogenic activity of ECPs produced by the VPAP30 strain remained intact after heat treatment, indicating the presence of thermo-resistant toxins. Otherwise, only naphthol-AS-Bi-phosphohydrolase activity remained in the heat treated ECPs, suggesting that enzymatic activities detected by the API ZYM system are not involved in the pathogenic activity of this strain. [@B41] reported an episode of larval mortality in reared larvae of *Argopecten purpuratus* identifying the causal agent as *V*. *anguillarum*-like and causing 30% mortality at 24 h post-infection, mainly mediated by the production of an extracellular toxin. [@B44] isolated 3 pathogenic strains identified as *V*. *splendidus*, which were recovered from different episodes of massive mortalities occurring in a commercial culture of the scallop larvae *A*. *purpuratus* in Chile, causing larval mortalities of approximately the 80% of challenged larvae at 48 h post-inoculation, and characterized by bacterial invasion of larval tissue as well as the production of ECPs toxigenic to *A*. *purpuratus* larvae.

Several proteins are secreted by *V*. *tubiashii* strains, including a low molecular weight ciliostatic toxin, which is a very important virulence factor in shellfish larval vibriosis ([@B34]). As previously described, a major trait of vibriosis is extensive necrosis followed by sudden death, which is consistent with the involvement of proteinases and haemolysins ([@B33]), as exhibited by scallop larvae inoculated with ECPs released by the VPAP30 strain.

A mollusc larvae pathogenic strain reclassified by [@B58] as *V. coralliilyticus* (formerly *V*. *tubiashii* ATCC 19105) produces some extracellular compounds, including a cytolysin/haemolysin ([@B18]) and a protease ([@B5]). More recently, [@B27] remarked on the importance of the production of metalloproteases in the pathogenic activity by this *V*. *europaeus* strain (formerly *V. tubiashii* ATCC 19105) on oyster larvae, detecting the production of a metalloprotease encoded by the *vtpA* gene. It must be noted that a metalloprotease encoding gene similar to *vtpA* was detected in the genome of this pathogenic strain (formerly *V*. *tubiashii* VPAP30) ([@B45]). Moreover, [@B17] demonstrated that metalloprotease inhibitors severely reduce the toxicity of ECPs produced by 2 strains recently identified as *V. coralliilyticus* ([@B58]; [@B38]), but previously miss-identified as *V. tubiashii*, on Pacific oyster larvae. In addition, the authors reported an inhibitory activity on its extracellular haemolysin of the extracellular metalloprotease produced by these strains ([@B16]).

Conclusion
==========

In conclusion, this is the first isolation of a *V*. *bivalvicida* strain outside Europe, being recovered from a massive mortality episode in a commercial larval culture of the scallop *A*. *purpuratus* in Chile. Our results demonstrated that *V*. *bivalvicida* VPAP30 is highly pathogenic to scallop larvae exhibiting an invasive activity as well as a production of toxigenic heat-stable ECPs and producing the typical clinical signs of vibriosis. In addition, this strain produced on experimentally infected scallop larval cultures very similar symptoms to those observed during the massive mortality event in the Chilean commercial hatchery strongly suggesting that this strain was the causative agent of the mass mortalities occurring in the referred event. Then, we have demonstrated for the first time the occurrence of a highly pathogenic strain of *V. bivalvicida* in a commercial hatchery of scallop *A. purpuratus*, suggesting this species can become in a pathogen of major concern for the Chilean pectinid industry. The proper identification of this bacterial pathogen causing epizootics in larval cultures is essential for developing efficient epidemiological management strategies to prevent and control outbreaks in Chilean intensive scallop larvae husbandry.
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